By Devika Patel
Knoxville, Tenn., Sept. 30 - Alexza Pharmaceuticals, Inc. will raise $19.72 million in a private placement of stock, according to an 8-K filed Wednesday with the Securities and Exchange Commission.
The company will sell 8,107,013 common shares at $2.4325 apiece.
Investors also will receive warrants for 7,296,312 shares. Each warrant is exercisable at $2.77 for seven years.
Settlement is expected Oct. 5.
RBC Capital Markets Corp. is the agent.
Proceeds will be used primarily for working capital and general corporate purposes.
Alexza is a Palo Alto, Calif., pharmaceutical company.
| Issuer: | Alexza Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $19,720,309
|
| Shares: | 8,107,013
|
| Price: | $2.4325
|
| Warrants: | For 7,296,312 shares
|
| Warrant expiration: | Seven years
|
| Warrant strike price: | $2.77
|
| Agent: | RBC Capital Markets Corp.
|
| Pricing date: | Sept. 30
|
| Settlement date: | Oct. 5
|
| Stock symbol: | Nasdaq: ALXA
|
| Stock price: | $2.25 at close Sept. 30
|
| Market capitalization: | $74.8 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
